Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Ovarian Cancer,2014,NCI,5R01CA079716-15,,Ovarian Cancer: Epithelial Dedifferentiation,"XU, XIANGXI MIKE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$316,620"
Ovarian Cancer,2014,NCI,5R01CA144057-10,,Evaluation of Vectors based on group B adenoviruses,"LIEBER, ANDRE",UNIVERSITY OF WASHINGTON,WA,"$319,059"
Ovarian Cancer,2014,NCI,5R01CA158415-03,,Heterocellular 3D ovarian tumor arrays for imaging and mechanistic combinations,"HASAN, TAYYABA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$413,258"
Ovarian Cancer,2014,NCI,5R01CA142838-05,,Role of redox state in ovarian cancer response to cisplatin,"DANIEL, LARRY",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$284,175"
Ovarian Cancer,2014,NCI,5R01CA142776-05,,"The role of microRNA, mir-30d, in the initiation and progression of cancer","ZHANG, LIN",UNIVERSITY OF PENNSYLVANIA,PA,"$312,379"
Ovarian Cancer,2014,NCI,2R01CA135650-05A1,,Predictive Cancer Diagnostics and Therapy Response,"MOORE, ANNA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$589,368"
Ovarian Cancer,2014,NCI,5R01CA138628-05,,Role of the BMP SMADs in Oncogenesis,"PANGAS, STEPHANIE",BAYLOR COLLEGE OF MEDICINE,TX,"$343,739"
Ovarian Cancer,2014,NCI,5P30CA006516-49,6051,Gynecologic Cancers,"BIRRER, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$88,496"
Ovarian Cancer,2014,NCI,5P30CA006516-49,6064,Cancer Epidemiology,"HANKINSON, SUSAN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$78,039"
Ovarian Cancer,2014,NCI,5R03CA173834-02,,Genetic Risk Prediction in Primary Care,"BISWAS, SWATI",UNIVERSITY OF TEXAS DALLAS,TX,"$80,031"
Ovarian Cancer,2014,NCI,5P30CA014236-40,6412,Breast and Ovarian Oncology,"BERCHUCK, ANDREW",DUKE UNIVERSITY,NC,"$41,083"
Ovarian Cancer,2014,NCI,5P30CA014236-40,6465,Protocol Specific Research Support,"LYERLY, HERBERT",DUKE UNIVERSITY,NC,"$222,891"
Ovarian Cancer,2014,NCI,5R01CA097061-11,,Chemical genetic profiling of engineered tumor cells,"STOCKWELL, BRENT",COLUMBIA UNIV NEW YORK MORNINGSIDE,NY,"$339,671"
Ovarian Cancer,2014,NCI,5R21CA156021-02,,Elafin as a biomarker in serous ovarian cancers and basal-like breast tumors,"DRAPKIN, RONNY",DANA-FARBER CANCER INST,MA,"$181,624"
Ovarian Cancer,2014,NCI,5R03CA173531-02,,LncRNA Pathways as Novel Diagnostic Biomarkers Derived from the Stroma of Epithel,"GAYTHER, SIMON",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$79,661"
Ovarian Cancer,2014,NCI,1U10CA180860-01,,Integrated Translational Genoproteomics Center at Washington University,"MUTCH, DAVID",WASHINGTON UNIVERSITY,MO,"$599,999"
Ovarian Cancer,2014,NCI,5R01CA108970-10,,CD4+ Memory T-Cells in Human Tumor Microenvironment,"BANKERT, RICHARD",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$287,818"
Ovarian Cancer,2014,NCI,5R01CA099985-08,,Human Tregs in Ovarian Cancer,"ZOU, WEIPING",UNIVERSITY OF MICHIGAN,MI,"$210,460"
Ovarian Cancer,2014,NCI,5R01CA142832-05,,Novel Biomarkers in Ovarian Cancer,"BIRRER, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$337,135"
Ovarian Cancer,2014,NCI,5R21CA167038-02,,MiR-182 overexpression in early tumorigenesis of high grade serous carcinoma,"WEI, JIAN-JUN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$162,979"
Ovarian Cancer,2014,NCI,5R01CA149429-05,,The Mitochondrial Genome and Ovarian Cancer Risk,"PHELAN, CATHERINE",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$554,433"
Ovarian Cancer,2014,NCI,5F31CA165853-03,,Therapeutic Targeting of Novel Antifolates to Solid Tumors via Folate Receptor,"MITCHELL, SHERMAINE",WAYNE STATE UNIVERSITY,MI,"$37,465"
Ovarian Cancer,2014,NCI,5R01CA174470-23,,Stimulation of Tumorigenesis by NKG2D,"SPIES, THOMAS",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$627,023"
Ovarian Cancer,2014,NCI,5R01CA140323-05,,Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer,"GODWIN, ANDREW",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$309,390"
Ovarian Cancer,2014,NCI,5R01CA047135-24,,Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics,"CREWS, PHIL",UNIVERSITY OF CALIFORNIA SANTA CRUZ,CA,"$626,963"
Ovarian Cancer,2014,NCI,5R01CA172743-02,,Impact of BRCA Testing on Newly Diagnosed U.S. Breast Cancer Patients,"SUTPHEN, REBECCA",UNIVERSITY OF SOUTH FLORIDA,FL,"$578,772"
Ovarian Cancer,2014,NCI,5R01CA102707-10,,Inhibition  of Cytochrome c-induced Caspase Activation,"KORNBLUTH, SALLY",DUKE UNIVERSITY,NC,"$255,163"
Ovarian Cancer,2014,NCI,5R01CA108990-10,,Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer,"LOKSHIN, ANNA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$549,452"
Ovarian Cancer,2014,NCI,1R01CA181090-01,,Regulation of DSB repair by 53BP1,"DE LANGE, TITIA",ROCKEFELLER UNIVERSITY,NY,"$519,021"
Ovarian Cancer,2014,NCI,5R01CA095298-13,,Cisplatin resistance mediated by copper export pathways,"HOWELL, STEPHEN",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$217,816"
Ovarian Cancer,2014,NCI,5R01CA174643-07,,The role of ERRalpha/PGC-1 in disease pathogenesis,"MCDONNELL, DONALD",DUKE UNIVERSITY,NC,"$304,783"
Ovarian Cancer,2014,NCI,5R01CA163462-03,,MUC1 Roles in ovarian cancer pathogenesis and immune therapy,"VLAD, ANDA",MAGEE-WOMEN'S RES INST AND FOUNDATION,PA,"$279,390"
Ovarian Cancer,2014,NCI,1U01CA181628-01,,Novel Activatable Fluorophores for Multicolor Fluorescence-Guided Cancer Surgery,"PTASZEK, MARCIN",UNIVERSITY OF MARYLAND BALT CO CAMPUS,MD,"$196,403"
Ovarian Cancer,2014,NCI,1R01CA181543-01,,Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells,"BRUGGE, JOAN",HARVARD MEDICAL SCHOOL,MA,"$398,239"
Ovarian Cancer,2014,NCI,5R01CA166711-02,,Purine Synthesis Inhibitors with Selective Folate Receptor Tumor Transport,"GANGJEE, ALEEM",DUQUESNE UNIVERSITY,PA,"$546,172"
Ovarian Cancer,2014,NCI,5R01CA155025-04,,The role of a novel BRCA1 associated complex in DNA damage response and tumor sup,"WANG, BIN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$318,015"
Ovarian Cancer,2014,NCI,5R01CA039742-30,,Epidemiology of Cancer in a Cohort of Older Women,"LAZOVICH, DEANN",UNIVERSITY OF MINNESOTA,MN,"$425,846"
Ovarian Cancer,2014,NCI,1R15CA173688-01A1,,EPO Increases Macrophage Suppression,"RIGGS, JAMES",RIDER UNIVERSITY,NJ,"$364,593"
Ovarian Cancer,2014,NCI,5R01CA163345-03,,Targeting Ovarian Tumor Associated Myeloid Cells with Nanoparticles Therapeutics,"BUCKANOVICH, RONALD",UNIVERSITY OF MICHIGAN,MI,"$312,983"
Ovarian Cancer,2014,NCI,5R01CA169604-02,,Metabolic changes in ovarian cancer cells initiated by metastasis to adipose tiss,"LENGYEL, ERNST",UNIVERSITY OF CHICAGO,IL,"$318,015"
Ovarian Cancer,2014,NCI,5UM1CA173642-02,,Women's Health Initiative Cancer Survivor Cohort,"ANDERSON, GARNET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$2,232,714"
Ovarian Cancer,2014,NCI,1R03CA181907-01,,Diagnostic Utility of Culdocentesis in Patients with a Suspicious Adnexal Mass,"BRARD, LAURENT",SOUTHERN ILLINOIS UNIVERSITY SCH OF MED,IL,"$73,750"
Ovarian Cancer,2014,NCI,1R03CA182120-01,,"Inflammation, autoimmunity and ovarian cancer","LUBORSKY, JUDITH",WOODS HOLE OCEANOGRAPHIC INSTITUTION,MA,"$68,300"
Ovarian Cancer,2014,NCI,5R01CA174904-02,,Roles of Chromatin Modification in BRCA1 Dependent DNA Repair,"GREENBERG, ROGER",UNIVERSITY OF PENNSYLVANIA,PA,"$322,040"
Ovarian Cancer,2014,NCI,5R01CA157664-04,,Initiation and evolution of the ovarian cancer microenvironment,"CONEJO-GARCIA, JOSE",WISTAR INSTITUTE,PA,"$370,480"
Ovarian Cancer,2014,NCI,5R01CA149669-05,,CD73 and tumor immunity,"ZHANG, BIN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$302,537"
Ovarian Cancer,2014,NCI,1R21CA182715-01,,Bayesian Integrative Clustering for Determining Molecular Based Cancer Subty,"FRIDLEY, BROOKE",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$164,213"
Ovarian Cancer,2014,NCI,1R15CA176653-01A1,,Altered microRNA as a biomarker for the onset of obesity related womens cancers,"MURPH, MANDI",UNIVERSITY OF GEORGIA,GA,"$426,849"
Ovarian Cancer,2014,NCI,5R01CA169200-02,,The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer,"BIRRER, MICHAEL",MASSACHUSETTS GENERAL HOSPITAL,MA,"$360,890"
Ovarian Cancer,2014,NCI,1R01CA182832-01,,An Epigenetic Strategy for Restoring Carboplatin Sensitivity in Ovarian Cancer,"MATEI, DANIELA",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$323,700"
Ovarian Cancer,2014,NCI,5R01CA148826-04,,Characterizing Notch3 Signaling in Ovarian Cancer,"WANG, TIAN-LI",JOHNS HOPKINS UNIVERSITY,MD,"$330,091"
Ovarian Cancer,2014,NCI,5R00CA139006-04,,Development of Targeted Therapy for ERK Pathway in Breast Cancer,"BARTHOLOMEUSZ, CHANDRA",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$241,530"
Ovarian Cancer,2014,NCI,5U54CA113001-10,8572,Interrogating Epigenetic Changes in Cancer Genomes,"HUANG, TIM",OHIO STATE UNIVERSITY,OH,"$1,631,430"
Ovarian Cancer,2014,NCI,2R01CA132755-06A1,,Molecular Mechanisms of BRCA1-Dependent DNA Damage Response and Tumorogenesis,"YU, XIAOCHUN",UNIVERSITY OF MICHIGAN,MI,"$349,875"
Ovarian Cancer,2014,NCI,5R01CA099471-10,,Gonadotropins & Cox-2 in Ovarian Cancer Prevention,"XU, XIANGXI MIKE",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$364,927"
Ovarian Cancer,2014,NCI,5R01CA158119-03,,Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens,"CRAMER, DANIEL",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$474,155"
Ovarian Cancer,2014,NCI,5R01CA159042-04,,Personalizing Nanoparticle Therapy,"KUNDRA, VIKAS",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$314,496"
Ovarian Cancer,2014,NCI,5R21CA169739-02,,Integration and Evaluation of Pooled Cancer Studies with Heterogeneity,"LIU, MENGLING",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$210,453"
Ovarian Cancer,2014,NCI,5R21CA177233-02,,Novel Tools for Familial Risk Prediction,"PARMIGIANI, GIOVANNI",DANA-FARBER CANCER INST,MA,"$181,349"
Ovarian Cancer,2014,NCI,5F30CA167895-03,,Molecular analysis of the function of BRCA1-TONSL complexes,"HILL, SARAH",HARVARD MEDICAL SCHOOL,MA,"$45,318"
Ovarian Cancer,2014,NCI,2R01CA043054-27A1,,Nuclear Function of Abl in DNA Damage Response,"WANG, JEAN",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$387,500"
Ovarian Cancer,2014,NCI,5R01CA141078-05,,Multifunctional roles of homeobox gene DLX4 in ovarian cancer,"NAORA, HONAMI",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$308,475"
Ovarian Cancer,2014,NCI,5R01CA168758-02,,Epidemiologic factors and survival by molecular subtypes of ovarian cancer,"ROSSING, MARY",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$602,370"
Ovarian Cancer,2014,NCI,1R01CA176078-01A1,,Dissecting the role of STAT3 and targeting ovarian cancer,"KARUPPAIYAH, SELVENDIRAN",OHIO STATE UNIVERSITY,OH,"$331,080"
Ovarian Cancer,2014,NIAID,2R01AI033993-20,,Processed Antigen Characterization by Mass Spectrometry,"HUNT, DONALD",UNIVERSITY OF VIRGINIA,VA,"$641,956"
Ovarian Cancer,2014,NCI,5R01CA158881-04,,Integrated Image-Guided Targeted Therapy for Refractory Ovarian Cancer,"COLEMAN, TIMOTHY","NEMUCORE MEDICAL INNOVATIONS, INC.",MA,"$665,610"
Ovarian Cancer,2014,NCI,1UM1CA182910-01,,Shanghai Womens Health Study,"ZHENG, WEI",VANDERBILT UNIVERSITY,TN,"$1,360,662"
Ovarian Cancer,2014,NCI,5K22CA175262-02,,Cellular and Molecular Tumorsuppressor Processes Uncovered by DNA Fork Protection,"SCHLACHER, KATHARINA",SLOAN-KETTERING INST CAN RESEARCH,NY,"$200,340"
Ovarian Cancer,2014,NCI,1R03CA175462-01A1,,Trial Participation Decision Making in Ovarian Cancer Patients and Their Families,"RADECKI BREITKOPF, CARMEN",MAYO CLINIC ROCHESTER,MN,"$79,500"
Ovarian Cancer,2014,NCI,1K99CA175292-01A1,,Targeting Determinants of OvCa Metastases in Engineered 3D Microfluidic Platforms,"RIZVI, IMRAN",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$174,871"
Ovarian Cancer,2014,NCI,1R01CA183040-01,,Ovarian cancer gene therapy using HPV pseudovirion,"WU, TZYY-CHOOU",JOHNS HOPKINS UNIVERSITY,MD,"$336,150"
Ovarian Cancer,2014,NCI,5R03CA172944-02,,Urinary metalloproteinases and ovarian cancer risk in a prospective cohort,"BUTLER, LESLEY",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$78,537"
Ovarian Cancer,2014,NCI,5R01CA148747-05,,Targeting the Mullerian Inhibiting Substance pathway in gynecologic cancer,"CLIBY, WILLIAM",MAYO CLINIC ROCHESTER,MN,"$307,889"
Ovarian Cancer,2014,OD,1S10OD018202-01,,Special BD LSR Fortessa,"PATANKAR, MANISH",UNIVERSITY OF WISCONSIN-MADISON,WI,"$350,505"
Ovarian Cancer,2014,NCI,1F31CA176995-01A1,,The Biochemical Contributions of Ovulation to Fallopian Tube Tumorigenesis,"FREELAND, MEGAN",HARVARD MEDICAL SCHOOL,MA,"$30,080"
Ovarian Cancer,2014,NCI,5R01CA086984-15,,Regulation of Ovarian Carcinoma Proteinases,"STACK, MARY",UNIVERSITY OF NOTRE DAME,IN,"$286,600"
Ovarian Cancer,2014,NCI,1F31CA177325-01A1,,Inflammatory Basis of Depression in Ovarian Cancer,"SCHREPF, ANDREW",UNIVERSITY OF IOWA,IA,"$30,152"
Ovarian Cancer,2014,NCI,1R43CA183195-01,,Synthesis and evaluation of novel kinase inhibitors as anti-metastasis agents for,"TUCCI, FABIO","EPIGEN BIOSCIENCES, INC.",CA,"$225,000"
Ovarian Cancer,2014,NCI,1R43CA180330-01A1,,Monobody therapy for gynecologic cancers,"LARRICK, JAMES","PANORAMA RESEARCH, INC.",CA,"$225,000"
Ovarian Cancer,2014,NCI,1R43CA183379-01,,Tumor Tight Junction Opener + Chemotherapy Conjugates to Treat Cancer,"CARTER, DARRICK","PAI LIFE SCIENCES, INC.",WA,"$191,159"
Ovarian Cancer,2014,NCI,1F31CA183463-01,,Regulation of REDD1 and caspase-2 by FASN inhibition in ovarian cancer,"LINDBLOM, KELLY",DUKE UNIVERSITY,NC,"$32,882"
Ovarian Cancer,2014,NCI,1R43CA180323-01A1,,Ovarian cancer therapy using CD40 Ligand (CD40L),"KORNBLUTH, RICHARD","MULTIMERIC BIOTHERAPEUTICS, INC.",CA,"$223,899"
Ovarian Cancer,2014,NCI,1R43CA177146-01A1,,Multiplexed Ovarian Cancer Microfluidic Tissue Microarray,"BROOKS, BENJAMIN",WASATCH MICROFLUIDICS,UT,"$225,000"
Ovarian Cancer,2014,NCI,1F30CA183395-01,,Control of the apoptosome in epithelial ovarian cancer to enhance chemotherapy,"COCCE, KIMBERLY",DUKE UNIVERSITY,NC,"$33,087"
Ovarian Cancer,2014,NCI,1F31CA183547-01,,Epigenetics and Risk Factors for Breast and Ovarian Cancer in High Risk Women,"FERRIS, JENNIFER",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$41,199"
Ovarian Cancer,2014,NCI,1F31CA183531-01,,Targeting Gain-of-Function p53 Missense Mutants,"SHAVER, TIMOTHY",VANDERBILT UNIVERSITY,TN,"$27,328"
Ovarian Cancer,2014,NCI,5U01CA176058-02,,The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center,"HAHN, WILLIAM",DANA-FARBER CANCER INST,MA,"$693,679"
Ovarian Cancer,2014,NIBIB,5R01EB016582-02,,Tissue-dynamics Imaging for Therapeutic Efficacy in Ovarian Cancer,"NOLTE, DAVID",PURDUE UNIVERSITY,IN,"$321,812"
Ovarian Cancer,2014,NCI,5U01CA176270-02,,Profiling cancer neoantigen repertoires and validating immunotherapy targets,"MCINTOSH, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$1,047,882"
Ovarian Cancer,2014,NCI,5R01CA031841-34,,Synthetic Studies on Tumor Promoters and Inhibitors,"WENDER, PAUL",STANFORD UNIVERSITY,CA,"$313,323"
Ovarian Cancer,2014,NCI,5R01CA115483-10,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$281,879"
Ovarian Cancer,2014,NCI,5R01CA149260-05,,Improving the Efficacy of Cisplatin-Based Cancer Chemotherapy,"KUO, MACUS",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$308,475"
Ovarian Cancer,2014,NCI,5R01CA151570-04,,Co-registered photoacoustic and ultrasound  imaging  for non-invasive ovarian can,"ZHU, QUING",UNIVERSITY OF CONNECTICUT STORRS,CT,"$314,441"
Ovarian Cancer,2014,NCI,5R01CA152470-04,,Memory T Cells in the Tumor Microenvironment,"ZOU, WEIPING",UNIVERSITY OF MICHIGAN,MI,"$381,250"
Ovarian Cancer,2014,NCI,5R01CA154460-04,,CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res,"SANTIN, ALESSANDRO",YALE UNIVERSITY,CT,"$335,123"
Ovarian Cancer,2014,NCI,5R01CA160687-04,,Targeted Development of Platinum Drugs,"SIDDIK, ZAHID",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$318,015"
Ovarian Cancer,2014,NCI,5R01CA160998-04,,Ovarian Cancer PDT: Multi-intracellular targeting and Image-guided dosimetry,"HASAN, TAYYABA",MASSACHUSETTS GENERAL HOSPITAL,MA,"$370,925"
Ovarian Cancer,2014,NCI,5R01CA149356-14,,The Role of MicroRNAs in Tumor Progression,"PETER, MARCUS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$263,917"
Ovarian Cancer,2014,NCI,5R01CA142783-05,,Signaling in the ovarian cancer metastatic microenvironment,"SLACK-DAVIS, JILL",UNIVERSITY OF VIRGINIA,VA,"$300,665"
Ovarian Cancer,2014,NCI,5R01CA160669-03,,Mitochondrial DNA and Ovarian Cancer Risk and Survival,"COOK, LINDA",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$397,213"
Ovarian Cancer,2014,NCI,5U01CA168409-03,,COMPUTATIONAL AND FUNCTIONAL APPROACHES TO VALIDATING CANCER GENOME TARGETS,"POWERS, SCOTT",COLD SPRING HARBOR LABORATORY,NY,"$1,397,036"
Ovarian Cancer,2014,NIBIB,5R01EB007268-07,,Designing Magnetic Resonance Protein-based Contrast Agents with High Relaxivity,"YANG, JENNY",GEORGIA STATE UNIVERSITY,GA,"$417,812"
Ovarian Cancer,2014,NCI,5P01CA087969-15,7547,Ovarian Cancer,"TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$161,440"
Ovarian Cancer,2014,NCI,5P01CA087969-15,7548,Statistical Methods,"ROSNER, BERNARD",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$107,521"
Ovarian Cancer,2014,NCI,5P01CA087969-15,7551,Biologic Specimen Management Core,"TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$403,092"
Ovarian Cancer,2014,NCI,5K07CA143047-05,,Genetic Epidemiology of Ovarian and Prostate Cancer,"SIEH, WEIVA",STANFORD UNIVERSITY,CA,"$173,335"
Ovarian Cancer,2014,NCI,5K08CA148887-05,,Targeting Histone Deacetylases with Small Moleule Inhibitors in Ovarian Cancer,"KHABELE, DINEO",VANDERBILT UNIVERSITY,TN,"$159,084"
Ovarian Cancer,2014,NCI,1R01CA184717-01,,The Regulation of Cisplatin resistance in ovarian cancer,"ZHU, WENGE",GEORGE WASHINGTON UNIVERSITY,DC,"$328,888"
Ovarian Cancer,2014,NCI,5R01CA138533-05,,Multifunctional Nanotherapeutics for Cancer Treatment and Imaging,"MINKO, TAMARA","RUTGERS, THE STATE UNIV OF N.J.",NJ,"$300,860"
Ovarian Cancer,2014,NCI,1K99CA184043-01,,Targeting Ovarian Cancer via Cooperative Oncogene Interactions,"HARGREAVES, DIANA",STANFORD UNIVERSITY,CA,"$171,072"
Ovarian Cancer,2014,NCI,5P01CA066726-17,5805,Clinical Trials in Mesothelioma,"STERMAN, DANIEL",UNIVERSITY OF PENNSYLVANIA,PA,"$296,893"
Ovarian Cancer,2014,NCI,5R01CA163377-03,,Role of EZH2 in Epithelial Ovarian Cancer,"ZHANG, RUGANG",WISTAR INSTITUTE,PA,"$335,124"
Ovarian Cancer,2014,NCI,5R01CA068682-23,,Biomedical Applications of Expanded Porphyrins,"SESSLER, JONATHAN","UNIVERSITY OF TEXAS, AUSTIN",TX,"$310,970"
Ovarian Cancer,2014,NCI,1K99CA184415-01,,Functional Analysis of LncRNAs in Epithelial Ovarian Cancer,"LAWRENSON, KATE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$96,955"
Ovarian Cancer,2014,NCI,5R01CA109545-08,,Receptor Cross-Talk in Early Metastatic Dissemination,"STACK, MARY",UNIVERSITY OF NOTRE DAME,IN,"$289,107"
Ovarian Cancer,2014,NCI,5U01CA152990-05,,Proteomic Genetic and Longitudinal Paths to Ovarian Cancer Biomarker Discovery,"SKATES, STEVEN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$902,673"
Ovarian Cancer,2014,NCI,5R01CA111882-08,,Regulation of Adhesion and Proteolysis in Ovarian Cancer,"LENGYEL, ERNST",UNIVERSITY OF CHICAGO,IL,"$264,148"
Ovarian Cancer,2014,NCI,1R01CA184502-01,,(PQD5) Avatar-directed Treatment for Ovarian Cancer,"HALUSKA, PAUL",MAYO CLINIC ROCHESTER,MN,"$621,606"
Ovarian Cancer,2014,NCI,5R01CA075334-17,,MRI studies of angiogenesis in ovarian cancer,"NEEMAN, MICHAL",WEIZMANN INSTITUTE OF SCIENCE,ISRAEL,"$99,689"
Ovarian Cancer,2014,NCI,5R01CA164729-03,,"Integrative Cancer Genomics: Drivers, Pathways and Drugs","PE'ER, DANA",COLUMBIA UNIV NEW YORK MORNINGSIDE,NY,"$101,640"
Ovarian Cancer,2014,NCI,5R21CA177865-02,,Defining SPINK1 as a tumor driver and therapeutic target in ovarian cancer,"RADISKY, EVETTE",MAYO CLINIC  JACKSONVILLE,FL,"$165,673"
Ovarian Cancer,2014,NCI,1R01CA184968-01,,(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian Cancers,"SIKIC, BRANIMIR",STANFORD UNIVERSITY,CA,"$509,161"
Ovarian Cancer,2014,NCCAM,5R01AT005295-04,,Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian Cancer,"HALES, DALE",SOUTHERN ILLINOIS UNIVERSITY CARBONDALE,IL,"$349,309"
Ovarian Cancer,2014,NCI,5U01CA152637-05,,Breast and Ovary Cancer Clinical Validation Center,"LI, CHRISTOPHER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$725,717"
Ovarian Cancer,2014,NCI,5R01CA166907-02,,Transplatin: A Novel Agent to Mitigate Cisplatin Toxicity,"RAMKUMAR, VICKRAM",SOUTHERN ILLINOIS UNIVERSITY SCH OF MED,IL,"$291,855"
Ovarian Cancer,2014,NCI,5R01CA172272-02,,The BARD1 tumor suppressor and breast cancer,"BAER, RICHARD",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$322,040"
Ovarian Cancer,2014,NIGMS,1R15GM110615-01,,Ubiquitin-mediated regulation of the RAD51D homologous recombination protein,"PITTMAN, DOUGLAS",UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA,SC,"$325,326"
Ovarian Cancer,2014,NCI,1R21CA178255-01A1,,Upregulation of Nanog as an Innovative Mechanism for Cancer Drug Resistance.,"WU, TZYY-CHOOU",JOHNS HOPKINS UNIVERSITY,MD,"$211,410"
Ovarian Cancer,2014,NCI,5K23CA159391-03,,Anti-Tumor Immunity in Response to a Modified Vaccine Strain Measles Virus,"PEIKERT, TOBIAS",MAYO CLINIC ROCHESTER,MN,"$164,160"
Ovarian Cancer,2014,NIGMS,5R01GM032136-32,,Molecular Recognition of Proteins and Ligand Design,"JORGENSEN, WILLIAM",YALE UNIVERSITY,CT,"$369,146"
Ovarian Cancer,2014,NCI,2P30CA010815-45,6194,Tumor Microenvironment and Metastasis,"ALTIERI, DARIO",WISTAR INSTITUTE,,"$31,554"
Ovarian Cancer,2014,NCI,1R21CA185730-01,,Blood-based Angiome Profiling  to Direct Bevacizumab Therapy in Ovarian Cancer,"SECORD, ANGELES",DUKE UNIVERSITY,NC,"$170,738"
Ovarian Cancer,2014,NCI,1R21CA175975-01A1,,Reactive Oxygen Species-Induced CXCL8 in Ovarian Cancer,"PEIPER, STEPHEN",THOMAS JEFFERSON UNIVERSITY,PA,"$202,493"
Ovarian Cancer,2014,NCI,5R01CA180769-06,,Signaling Connections Controlling Cell Motility and Invasion,"SCHLAEPFER, DAVID",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$367,112"
Ovarian Cancer,2014,NCI,5R01CA164122-03,,B7-H1 Signaling in Ovarian Cancer,"CURIEL, TYLER",UNIVERSITY OF TEXAS HLTH SCIENCE CENTER,TX,"$300,907"
Ovarian Cancer,2014,NCI,5P30CA046592-26,6455,Cancer Genetics,"WICHA, MAX",UNIVERSITY OF MICHIGAN,MI,"$221,343"
Ovarian Cancer,2014,NCI,5R01CA158318-04,,mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity,"ODUNSI, KUNLE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$332,586"
Ovarian Cancer,2014,NCI,5R01CA112240-09,,The role of Fas as tumor promoter,"PETER, MARCUS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$285,323"
Ovarian Cancer,2014,NICHD,5R00HD059985-05,,GPR30 Mediated-Estrogen Action on Ovarian Physiology and Ovarian Cancer,"WANG, CHENG",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$233,602"
Ovarian Cancer,2014,NCI,5U01CA168870-03,,Glycomics Laboratory for the Early Detection of Epithelial Ovarian Cancer,"ABBOTT, KAREN",UNIV OF ARKANSAS FOR MED SCIS,AR,"$439,135"
Ovarian Cancer,2014,NCI,5U01CA113916-10,,Fox Chase Clinical Epidemiology and Validation Center,"ENGSTROM, PAUL",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$689,613"
Ovarian Cancer,2014,NCI,2R01CA109298-10,,Ovarian Cancer: Mechanisms of Neuroendocrine Regulation,"SOOD, ANIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$384,255"
Ovarian Cancer,2014,NCI,5R01CA124515-09,,Vascular Leukocytes Influence the Tumor Microenvironment,"CONEJO-GARCIA, JOSE",WISTAR INSTITUTE,PA,"$330,726"
Ovarian Cancer,2014,NIAID,5K06AI004739-53,,BIOCHEMISTRY OF VIRAL REPLICATION,"GREEN, MAURICE",SAINT LOUIS UNIVERSITY,MO,"$33,939"
Ovarian Cancer,2014,NCI,5U01CA151648-06,,RNA Nanotechnology in Cancer Therapy,"GUO, PEIXUAN",UNIVERSITY OF KENTUCKY,KY,"$377,580"
Ovarian Cancer,2014,NCI,5R01CA177909-02,,Platelets promote growth of ovarian cancer,"AFSHAR-KHARGHAN, VAHID",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$322,040"
Ovarian Cancer,2014,NCI,5U01CA084955-15,,Atlantic Breast and Gynecologic Clinical Validation Center,"MARKS, JEFFREY",DUKE UNIVERSITY,NC,"$483,318"
Ovarian Cancer,2014,NCI,5R01CA163451-03,,"Psychological stress, associate biologic mediators, and ovarian cancer risk","TWOROGER, SHELLEY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$399,742"
Ovarian Cancer,2014,NCI,5R01CA164940-03,,A Novel Approach for the Routine Screening for Ovarian Cancer,"PANNELL, LEWIS",UNIVERSITY OF SOUTH ALABAMA,AL,"$344,273"
Ovarian Cancer,2014,NCI,5U54CA151819-05,8878,"Organ-specific, Blood Protein Biomarkers for an Informative Diagnosis of Brain an","HOOD, LEROY",INSTITUTE FOR SYSTEMS BIOLOGY,WA,"$664,991"
Ovarian Cancer,2014,NCI,5U54CA151819-05,8879,Novel Nanotechnologies and Molecular Imaging Approaches for Cancer Immunotherapy,"RADU, CAIUS",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$352,248"
Ovarian Cancer,2014,NCI,5U54CA151819-05,8883,Administrative Core,"HEATH, JAMES",CALIFORNIA INSTITUTE OF TECHNOLOGY,CA,"$107,769"
Ovarian Cancer,2014,NCI,5F31CA174316-03,,Structural mutation analysis of PTEN and its possible genotype-phenotype correlat,"SMITH, IRIS",UNIVERSITY OF HOUSTON,TX,"$28,178"
Ovarian Cancer,2014,NCI,5U54CA151662-05,8769,Optimization of Nanoparticle Targeting in Ovarian and Breast Cancer,"GERNGROSS, TILLMAN",DARTMOUTH COLLEGE,NH,"$240,852"
Ovarian Cancer,2014,NCI,5U54CA151662-05,8772,Magnetic nanoparticle Immunotherapy against Ovarian Cancer,"CONEJO-GARCIA, JOSE",DARTMOUTH COLLEGE,NH,"$289,058"
Ovarian Cancer,2014,NCI,5U54CA151662-05,8775,"Toxicology, Pathology and Biodistribution Core (TPB Core)","LEWIS, LIONEL",DARTMOUTH COLLEGE,NH,"$158,492"
Ovarian Cancer,2014,NCI,5U54CA151881-05,5122,Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA,"TORCHILIN, VLADIMIR",NORTHEASTERN UNIVERSITY,MA,"$721,016"
Ovarian Cancer,2014,NCI,5U54CA151881-05,5124,Combination Nanotherapeutic Strategies to Overcome Tumor Drug Resistance,"MINKO, TAMARA",RUTGERS THE STATE UNIVERSITY OF NJ,NJ,"$254,447"
Ovarian Cancer,2014,NCI,5R01CA151374-05,,Evaluation of In Vivo Optical Imaging in Pancreatic and Ovarian Cancer Patients,"MARTIN, LAINIE",RESEARCH INST OF FOX CHASE CAN CTR,PA,"$147,300"
Ovarian Cancer,2014,NCI,5R01CA151248-04,,Role of DDB2 in chemotherapeutic agents-induced apoptosis and platinum resistance,"WANG, QIEN",OHIO STATE UNIVERSITY,OH,"$245,556"
Ovarian Cancer,2014,NCI,5U01CA151461-05,,Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian Cancer,"O'HALLORAN, THOMAS",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$417,627"
Ovarian Cancer,2014,RMAP,5UH2TR000943-02,,Novel extra cellular RNA-based combinatorial RNA inhibition therapy,"SOOD, ANIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$500,000"
Ovarian Cancer,2014,NCI,5K07CA166210-02,,Chemotherapy Near Death: Modifiable Factors and Outcomes in Ovarian Cancer,"WRIGHT, ALEXI",DANA-FARBER CANCER INST,MA,"$177,120"
Ovarian Cancer,2014,NCI,5R01CA172404-02,,Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer,"RAMUS, SUSAN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$568,855"
Ovarian Cancer,2014,NCI,5R01CA085566-11,,Psychological Intervention for Ovarian Cancer Patients,"MANNE, SHARON",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$417,701"
Ovarian Cancer,2014,NIGMS,1R01GM111093-01,,Glycosylation-dependent mechanisms regulating ovarian tumor cell survival,"BELLIS, SUSAN",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$279,300"
Ovarian Cancer,2014,NIGMS,1F32GM110978-01,,Deciphering the epistatic relationships of RAD51 Paralogs in mammary epithelium,"PRAKASH, ROHIT",SLOAN-KETTERING INST CAN RESEARCH,NY,"$56,978"
Ovarian Cancer,2014,NCI,5K22CA166226-03,,Targeting c-MYC Overcomes Temsirolimus and Cisplatin Resistance of Ovarian Cancer,"VIVAS-MEJIA, PABLO",UNIVERSITY OF PUERTO RICO MED SCIENCES,PR,"$171,827"
Ovarian Cancer,2014,NCI,1F31CA186625-01,,Refining ovarian cancer subtype classifiers to incorporate biologic features,"RUDD, JAMES",DARTMOUTH COLLEGE,NH,"$42,676"
Ovarian Cancer,2014,NCI,5R01CA178535-02,,The contribution of rare alleles to ovarian cancer in the population,"GAYTHER, SIMON",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$598,855"
Ovarian Cancer,2014,NCI,1R41CA180773-01A1,,Ovarian cancer using novel nanoparticle formulations,"CHIRIVA-INTERNATI, MAURIZIO","KIROMIC, LLC",TX,"$121,003"
Ovarian Cancer,2014,NCI,5R01CA175480-02,,Tumor-targeted Polymersomes to image and Treat Ovarian Cancer,"CHENG, ZHILIANG",UNIVERSITY OF PENNSYLVANIA,PA,"$318,010"
Ovarian Cancer,2014,NCI,5R21CA165916-03,,Models for Consortium Level Analysis of GxE Interaction in Complex Disease,"IVERSEN, EDWIN",DUKE UNIVERSITY,NC,"$99,369"
Ovarian Cancer,2014,NCI,5K01CA172591-03,,"EGF receptor, DNA methylation and platinum resistance in ovarian cancer","SAMUDIO-RUIZ, SABRINA",UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR,NM,"$129,216"
Ovarian Cancer,2014,NCI,5U01CA151452-05,,COMBINATORIAL-DESIGNED NANO-PLATFORMS TO OVERCOME TUMOR DRUG RESISTANCE,"AMIJI, MANSOOR",NORTHEASTERN UNIVERSITY,MA,"$400,638"
Ovarian Cancer,2014,NCI,5U54CA151884-05,5023,Nanoformulations for siRNA Delivery to Ovarian Cancer,"SHARP, PHILLIP",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$253,113"
Ovarian Cancer,2014,NCI,5P30CA118100-10,6320,Womens Cancers Research Program,"PROSSNITZ, ERIC",UNIVERSITY OF NEW MEXICO,NM,"$39,023"
Ovarian Cancer,2014,NCI,5R01CA131407-07,,Re-activating Memory T Cells in the Microenvironment of Human Tumors,"BANKERT, RICHARD",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$319,024"
Ovarian Cancer,2014,NCI,5R01CA142081-05,,Epidemiology of Ovarian Cancer in African-American Women,"SCHILDKRAUT, JOELLEN",DUKE UNIVERSITY,NC,"$2,304,983"
Ovarian Cancer,2014,NCI,5R01CA178687-02,,Effects of common polymorphisms in immune sensors in tumor immunosurveillance,"CONEJO-GARCIA, JOSE",WISTAR INSTITUTE,PA,"$366,633"
Ovarian Cancer,2014,NCI,5R01CA077398-16,,Breast and Other Cancers in the California Teachers Cohort,"BERNSTEIN, LESLIE",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$2,424,791"
Ovarian Cancer,2014,NCI,5U54CA151459-05,8855,Next Generation Smart Nanoparticles,"RAO, JIANGHONG",UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB,CA,"$973,458"
Ovarian Cancer,2014,NCI,5U54CA151459-05,8856,Magneto-Nano Diagnostic and Analytical Devices for Cancer,"WANG, SHAN",STANFORD UNIVERSITY,CA,"$236,780"
Ovarian Cancer,2014,NCI,5U54CA151459-05,8858,Integration of Nano-Molecular Imaging and Nanosensors,"GAMBHIR, SANJIV",STANFORD UNIVERSITY,CA,"$155,794"
Ovarian Cancer,2014,NIGMS,5R01GM097495-04,,"Cross-talk between PKA, cellular tension, and Ca2+ channels during cell migration","HOWE, ALAN",UNIVERSITY OF VERMONT & ST AGRIC COLLEGE,VT,"$289,750"
Ovarian Cancer,2014,NCI,5R21CA179680-02,,A Novel IgE Cancer Therapeutic Specific for the Epithelial Membrane Protein-2,"DANIELS-WELLS, TRACY",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$194,941"
Ovarian Cancer,2014,NCI,5U54CA163071-03,7991,Identifying Cancer Health Communication Channels for Hispanic Audiences,"JIMENEZ, JUILO",PONCE SCHOOL OF MEDICINE,PR,"$87,047"
Ovarian Cancer,2014,NIDDK,5R01DK087843-05,,Acute Kidney Injury by Cisplatin and Renoprotective Strategies,"DONG, ZHENG",GEORGIA  REGENTS UNIVERSITY,GA,"$308,138"
Ovarian Cancer,2014,NCI,5U54CA163068-03,8073,Identifying Cancer Health Communication Channels for Hispanic Audiences,"QUINN, GWENDOLYN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$79,530"
Ovarian Cancer,2014,NCI,5K99CA166228-02,,A Pathway-based Approach to Investigate Oncogenic Mechanisms in Ovarian Cancer,"GATZA, MICHAEL",UNIV OF NORTH CAROLINA CHAPEL HILL,NC,"$99,860"
Ovarian Cancer,2014,NIBIB,5F32EB017614-02,,LbL Nanotechnologies for Synergistic Therapy of Advanced Ovarian Carcinoma,"DREADEN, ERIK",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$53,282"
Ovarian Cancer,2014,NCI,5P50CA083639-15,7762,P1 - Early Detection of Epithelial Ovarian Cancer,"BAST, ROBERT",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$874,829"
Ovarian Cancer,2014,NCI,5P50CA083639-15,7764,P2 - Targeting DII4-Notch Signaling in Ovarian Cancer,"SOOD, ANIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$185,714"
Ovarian Cancer,2014,NCI,5P50CA083639-15,7767,P3 - Personalized Therapy for Low-Grade Serous Carcinoma of the Ovary,"GERSHENSON, DAVID",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$186,712"
Ovarian Cancer,2014,NCI,5P50CA083639-15,7768,P4 - Pers. Therapy for High-Grade Ovarian Cancer: Targeting PI3Kness & BRCAne,"MILLS, GORDON",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$163,151"
Ovarian Cancer,2014,NCI,5P50CA083639-15,7770,P5 - Gene-modified MSCs for Controlling Ovarian Cancer,"MARINI, FRANK",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$167,499"
Ovarian Cancer,2014,NCI,5P50CA083639-15,7771,Administrative Core,"GERSHENSON, DAVID",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$23,449"
Ovarian Cancer,2014,NCI,5P50CA083639-15,7772,"Biostatistics, Bioinformatics and Systems Biology (BBSB) Core","ATKINSON, E",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$257,582"
Ovarian Cancer,2014,NCI,5P50CA083639-15,7773,Pathology Core,"BROADDUS, RUSSELL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$109,268"
Ovarian Cancer,2014,NCI,5P50CA083639-15,7774,Developmental Research Program,"GERSHENSON, DAVID",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$75,373"
Ovarian Cancer,2014,NCI,5P50CA083639-15,7775,Career Developmental Program,"GERSHENSON, DAVID",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$50,249"
Ovarian Cancer,2014,NICHD,5R01HD073499-02,,Genetic regulation of ovariole development in Drosophila,"EXTAVOUR, CASSANDRA",HARVARD UNIVERSITY,MA,"$308,462"
Ovarian Cancer,2014,NCI,5R01CA157481-03,,"Bmi-1, a potential therapeutic target in ovarian cancer","BHATTACHARYA, RESHAM",UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,OK,"$302,136"
Ovarian Cancer,2014,NCI,5R21CA177048-02,,Role of Malic Enzymes in Tumorigenesis,"YANG, XIAOLU",UNIVERSITY OF PENNSYLVANIA,PA,"$202,536"
Ovarian Cancer,2014,NCI,5R21CA180145-02,,(PQD3) The role and therapeutic potential of ZNF304 in Ovarian Cancer,"OZPOLAT, BULENT",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$168,781"
Ovarian Cancer,2014,NCI,5P01CA154292-04,5435,Risk Assessment in Community Practice: Developing Better Models,"KERLIKOWSKE, KARLA",GROUP HEALTH COOPERATIVE,WA,"$457,911"
Ovarian Cancer,2014,NIEHS,5R21ES020411-02,,"Cancer induction in the ovary by an environmental pollutant, dibenzo[a,l]pyrene","CHEN, KUN-MING",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$189,337"
Ovarian Cancer,2014,NCI,5R01CA163018-03,,Prospective Study of Serum MIS and Gynecologic Cancer Risk,"DORGAN, JOANNE",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$388,102"
Ovarian Cancer,2014,NCI,5R21CA179443-02,,Validation of a risk assessment decision rule for epithelial ovarian cancer,"URBAN, NICOLE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$166,258"
Ovarian Cancer,2014,OD,5R21CA179443-02,,Validation of a risk assessment decision rule for epithelial ovarian cancer,"URBAN, NICOLE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$19,400"
Ovarian Cancer,2014,NCI,5U54CA151668-05,8844,Multistage Vectors (MSV) for Ovarian Cancer Therapeutics,"LOPEZ-BERESTEIN, GABRIEL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$411,645"
Ovarian Cancer,2014,NCI,5U54CA151668-05,8845,Nanotechnology Platforms for Targeting Ovarian Cancer Vasculature,"SOOD, ANIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$402,282"
Ovarian Cancer,2014,NCI,5U54CA151668-05,8847,Multifunctional Nanoassemblies for Ligand-directed Imaging and Therapy of Endocri,"LIBUTTI, STEVEN",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$330,151"
Ovarian Cancer,2014,NCI,5R21CA178571-02,,Mechanisms of Prevention of Ovarian Cancer by Oral Contraceptives,"PEARCE, CELESTE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$163,190"
Ovarian Cancer,2014,NIGMS,5R44GM086937-03,,New Reagents for RNA-based Therapeutic Technologies,"YANG, XIANBIN","AM BIOTECHNOLOGIES, LLC",TX,"$477,211"
Ovarian Cancer,2014,NCI,1R21CA186846-01,,Integrated Microfluidic Exosome Profiling for Early Detection of Cancer,"ZENG, YONG",UNIVERSITY OF KANSAS LAWRENCE,KS,"$220,833"
Ovarian Cancer,2014,NCI,5K99CA179137-02,,"Understanding the origin,initiation,and progression of high-grade serous ovarian","KIM, JAEYEON",BAYLOR COLLEGE OF MEDICINE,TX,"$95,826"
Ovarian Cancer,2014,NCI,5U01CA170948-02,,Secondary Analysis of Longitudinal Trait in Genome Wide Association Studies - Res,"LI, HUILIN",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$82,208"
Ovarian Cancer,2014,NCI,5R01CA180710-02,,Targeting nucleotide excision repair in combination cancer therapy,"TURCHI, JOHN",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$313,989"
Ovarian Cancer,2014,NCI,1R01CA187209-01,,Functional analysis of BRCA1 in DNA damage response and tumor suppression,"YU, XIAOCHUN",UNIVERSITY OF MICHIGAN,MI,"$322,576"
Ovarian Cancer,2014,NCI,1R21CA187278-01,,Diagnostic Assays for OVCA Recurrence using Paraneoplastic Antigens and Epitopes,"TAINSKY, MICHAEL",WAYNE STATE UNIVERSITY,MI,"$165,300"
Ovarian Cancer,2014,NCI,1R21CA178468-01A1,,Transition from Endometriosis to Ovarian Cancer: Role of Iron-Induced Autophagy,"NANJUNDAN, MEERA",UNIVERSITY OF SOUTH FLORIDA,FL,"$193,984"
Ovarian Cancer,2014,RMAP,1DP2CA195766-01,,Analysis of how quantitative cellular network variation impacts tumor progression,"KREEGER, PAMELA",UNIVERSITY OF WISCONSIN-MADISON,WI,"$2,295,000"
Ovarian Cancer,2014,NCI,5P50CA159981-02,5590,"Inhibition of indole-amine 2,3 dioxygenase to Enhance Ovarian Tumor Immunity","ODUNSI, KUNLE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$656,160"
Ovarian Cancer,2014,NCI,5P50CA159981-02,5591,Rapamycin and IL-21 Conditioned CD8+ T Cells for Adoptive Cellular Therapy of Ov,"SHRIKANT, PROTUL",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$586,921"
Ovarian Cancer,2014,NCI,5P50CA159981-02,5593,MHC-Restricted and MHC-Non-Restricted Targeting of Ovarian Cancer by alphaDC1,"KALINSKI, PAWEL",UNIVERSITY OF PITTSBURGH,PA,"$441,496"
Ovarian Cancer,2014,NCI,5P50CA159981-02,5594,Myeloid Derived Suppressor Cells in Ovarian Carcinogenesis,"MOYSICH, KIRSTEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$85,698"
Ovarian Cancer,2014,NCI,5P50CA159981-02,5595,Administrative Core,"ODUNSI, KUNLE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$64,834"
Ovarian Cancer,2014,NCI,5P50CA159981-02,5596,Biospecimen Core,"MORRISON, CARL",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$64,403"
Ovarian Cancer,2014,NCI,5P50CA159981-02,5597,Biostatistics/Medical Informatics,"HUTSON, ALAN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$49,563"
Ovarian Cancer,2014,NCI,5P50CA159981-02,5598,Immune Monitoring Core,"WALLACE, PAUL",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$87,915"
Ovarian Cancer,2014,NCI,5P50CA159981-02,5599,Developmental Research Program,"MOYSICH, KIRSTEN",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$59,682"
Ovarian Cancer,2014,NCI,5P50CA159981-02,5600,Career Development Program,"LELE, SHASHIKANT",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$65,328"
Ovarian Cancer,2014,NCI,5U54CA096300-12,6961,In Vivo Assessment of Localized Magnetic Fluid Hyperthermia for Ovarian Cancer,"SOOD, ANIL",UNIVERSITY OF PUERTO RICO,PR,"$90,187"
Ovarian Cancer,2014,NCI,1R21CA187512-01,,TARGETING SPLEEN TYROSINE KINASE IN CHEMORESISTANT OVARIAN CARCINOMA,"WANG, TIAN-LI",JOHNS HOPKINS UNIVERSITY,MD,"$211,410"
Ovarian Cancer,2014,NCI,1R01CA181258-01A1,,Chemically Programmed Bispecific Antibodies for Cancer Therapy,"RADER, CHRISTOPH",SCRIPPS FLORIDA,FL,"$392,175"
Ovarian Cancer,2014,NCI,1R01CA188025-01,,Iron addiction and the biology of ovarian cancer,"TORTI, SUZY",UNIVERSITY OF CONNECTICUT SCH OF MED/DNT,CT,"$413,610"
Ovarian Cancer,2014,NCI,1R01CA181808-01A1,,Steroid Hormones Regulate Ovarian Cancer Progression and Metastasis,"RICHARDS, JOANNE",BAYLOR COLLEGE OF MEDICINE,TX,"$369,215"
Ovarian Cancer,2014,NCI,1R21CA187765-01,,"Genomic Instability from Loss of XPG, a BRCA1/2 Partner: Role in Ovarian Cancer?","COOPER, PRISCILLA",UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB,CA,"$255,796"
Ovarian Cancer,2014,NCI,1R21CA181923-01A1,,"Hormonal effects on fallopian tube and ovary inclusion cysts, and ovarian cancer","PIKE, MALCOLM",SLOAN-KETTERING INST CAN RESEARCH,NY,"$228,723"
Ovarian Cancer,2014,NCI,2R01CA131582-05A1,,Identification of Ovarian Cancer Plasma Biomarkers,"SPEICHER, DAVID",WISTAR INSTITUTE,PA,"$440,659"
Ovarian Cancer,2014,NCI,1R01CA176166-01A1,,Identifying Biomarkers of Cisplatin Resistance Mechanisms in Ovarian Cancer,"CANTOR, SHARON",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$345,176"
Ovarian Cancer,2014,NCI,5U24CA160036-04,,Proteome Characterization Center: A Genoproteomics Pipeline for Cancer Biomarkers,"CHAN, DANIEL",JOHNS HOPKINS UNIVERSITY,MD,"$1,890,981"
Ovarian Cancer,2014,OD,1R03CA178763-01A1,,Young Women From BRCA1/2 Families: A Family History And A Future,"O'NEILL, SUZANNE",GEORGETOWN UNIVERSITY,DC,"$77,750"
Ovarian Cancer,2014,NCI,1R21CA182748-01A1,,Targeting TF/CD44v6 for In Vivo Nano-generated  alpha-therapy of Ovarian Cancer,"DEUTSCHER, SUSAN",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$166,031"
Ovarian Cancer,2014,NIBIB,1R21EB019147-01,,Quantitative endoscopic imaging and structured light delivery for controlled drug,"SUNAR, ULAS",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$186,866"
Ovarian Cancer,2014,NCI,4R00CA168987-02,,Discovering genomic rearrangements under selection in serious ovarian cancer,"SALZMAN, JULIA",STANFORD UNIVERSITY,CA,"$241,530"
Ovarian Cancer,2014,NCI,2R42CA156933-02A1,,Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian Cancer,"KOPECEK, JINDRICH",THERATARGET,UT,"$502,857"
Ovarian Cancer,2014,NCI,1F30CA189316-01,,The Role of NFAT3 in Quiescence and Chemoresistance in Ovarian Cancer Stem Cells,"IYENGAR, MANGALA",UNIVERSITY OF MICHIGAN,MI,"$33,181"
Ovarian Cancer,2014,NCI,1F32CA183214-01A1,,The use of epigenetic therapy to activate an immune response in ovarian cancer,"CHIAPPINELLI, KATHERINE",JOHNS HOPKINS UNIVERSITY,MD,"$51,530"
Ovarian Cancer,2014,NCI,1R43CA183416-01A1,,Expression System and Process Development for MIS Scale Up,"COLEMAN, TIMOTHY","NEMUCORE MEDICAL INNOVATIONS, INC.",MA,"$224,915"
Ovarian Cancer,2014,NCI,5F30CA171718-02,,The Role of 53BP1 Interacting Proteins in Regulation of DNA Repair Choice,"GHEEYA, JINESH",RBHS -CANCER INSTITUTE OF NEW JERSEY,NJ,"$33,166"
Ovarian Cancer,2014,NCI,1R03CA189462-01,,Defining microRNA Signatures for Early Detection in BRCA-Mutated Ovarian Cancer,"DINULESCU, DANIELA",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$85,057"
Ovarian Cancer,2014,NCI,3U24CA160019-03S1,,Deep Proteomics of Normal Human Ovarian Surface Epithelium and Fallopian Tube Epi,"RODLAND, KARIN",BATTELLE PACIFIC NORTHWEST LABORATORIES,WA,"$67,089"
Ovarian Cancer,2014,NCI,3R01CA047135-24S1,,Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics,"CREWS, PHIL",UNIVERSITY OF CALIFORNIA SANTA CRUZ,CA,"$82,796"
Ovarian Cancer,2014,NCI,3R01CA140323-05S1,,Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer,"GODWIN, ANDREW",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$84,070"
Ovarian Cancer,2014,NCI,3R01CA140323-05S2,,Exploiting Biological Networks to Improve Clinical Treatment of Ovarian Cancer,"GODWIN, ANDREW",UNIVERSITY OF KANSAS MEDICAL CENTER,KS,"$107,546"
Ovarian Cancer,2014,NCI,3R01CA149669-05S1,,CD73 and tumor immunity,"ZHANG, BIN",NORTHWESTERN UNIVERSITY AT CHICAGO,IL,"$58,509"
Ovarian Cancer,2014,NCI,7K08CA151892-04,,Targeting SRC Signaling Pathways to Promote Cell Cycle Arrest in Ovarian Cancer,"SIMPKINS, FIONA",UNIVERSITY OF PENNSYLVANIA,PA,"$161,528"
Ovarian Cancer,2014,NCI,1U01CA184910-01A1,,Validation of findings from the Epigenome-Wide Association Study of Breast Cancer,"STURGEON, SUSAN",UNIVERSITY OF MASSACHUSETTS AMHERST,MA,"$518,726"
Ovarian Cancer,2014,NCI,3R01CA142783-05S1,,Signaling in the ovarian cancer metastatic microenvironment,"SLACK-DAVIS, JILL",UNIVERSITY OF VIRGINIA,VA,"$10,537"
Ovarian Cancer,2014,NCI,3R01CA115483-10S1,,Therapeutic Targeting Agents for Ovarian Cancer,"LAM, KIT",UNIVERSITY OF CALIFORNIA AT DAVIS,CA,"$51,944"
Ovarian Cancer,2014,NCI,1F31CA192891-01,,Evaluating Notch Signaling as a Therapeutic Target in Ovarian Cancer,"PRICE, JESSICA",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$43,443"
Ovarian Cancer,2014,RMAP,3UH2TR000943-02S1,,HPV Communication to Microenvironment via Exosomes,"SOOD, ANIL",UNIVERSITY OF TX MD ANDERSON CAN CTR,TX,"$80,000"
Ovarian Cancer,2014,NCI,261200800001E-66-0-36,,Repository Services for epidemiology studies,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",,"$1,671,271"
Ovarian Cancer,2014,NCI,261201100008C-11-0-1,,CENTRAL DATA COLLECTION CENTER (CDCC) CONTINUED FOLLOW-UP OF PLCO,"MATHEW, SUNITHA","WESTAT, INC.",,"$2,160,252"
Ovarian Cancer,2014,NIBIB,3R01EB007268-07S1,,Designing Magnetic Resonance Protein-based Contrast Agents with High Relaxivity,"YANG, JENNY",GEORGIA STATE UNIVERSITY,GA,"$40,437"
Ovarian Cancer,2014,NCI,261201400003C-0-0-1,,IGF::OT::IGF - IND ENABLING DEVELOPMENT OF NANOGMP: TARGETED,"LI, JUN","QUALIBER, INC.",NC,"$888,375"
Ovarian Cancer,2014,NCI,3U19CA148112-04S1,,Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI),"SELLERS, THOMAS",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$407,868"
Ovarian Cancer,2014,NCI,5U01CA152755-05,,An integrated systems biology approach for ovarian cancer biomarker discovery,"DIAMANDIS, ELEFTHERIOS",MT SINAI HOSP-SAMUEL LUNENFELD RES INST,CANADA,"$257,249"
Ovarian Cancer,2014,NCI,7F30CA171715-03,,Unusual Evolutionary Patterns in BRCA1 and their Implications for Cancer,"LOU, DIANNE",UNIVERSITY OF TEXAS MEDICAL BR GALVESTON,TX,"$36,276"
Ovarian Cancer,2014,NCI,3P30CA010815-45S1,,Consolidated Basic Cancer Research Program,"ALTIERI, DARIO",WISTAR INSTITUTE,PA,"$92,630"
Ovarian Cancer,2014,NCI,3P50CA136393-05S1,,Mayo Clinic SPORE in Ovarian Cancer,"KAUFMANN, SCOTT",MAYO CLINIC ROCHESTER,MN,"$622,294"
Ovarian Cancer,2014,NCI,3F31CA165528-02S1,,The Functional Analysis of Ovarian Cancer Susceptibility Locus 9p22.2,"BUCKLEY, MELISSA",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$32,955"
Ovarian Cancer,2014,NCI,5U54CA118948-09,8553,Development Core,"MANNE, UPENDER",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$507,196"
Ovarian Cancer,2014,NCI,261201400010C-0-0-1,,Replicating Tumor ECM in Microchannels for 3D Phenotypic HTS Assays,"LOWERY, ROBERT","BELLBROOK LABS, LLC",WI,"$225,000"
Ovarian Cancer,2014,NCI,1ZIABC006161-31,,DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs,"POMMIER, YVES",NIH,,"$946,675"
Ovarian Cancer,2014,NCI,1ZIABC009052-25,,Papillomavirus Virion Proteins and Vaccines,"SCHILLER, JOHN",NIH,,"$2,060,667"
Ovarian Cancer,2014,NCI,1ZIABC010549-12,,Zebrafish Models of Cancer,"HICKSTEIN, DENNIS",NIH,,"$591,158"
Ovarian Cancer,2014,NCI,1ZIABC010657-10,,Intracellular In vivo Imaging,"CHOYKE, PETER",NIH,,"$977,297"
Ovarian Cancer,2014,NCI,1ZIABC010661-10,,Vaccine and Drug Combination Therapy for Human Cancers,"HODGE, JAMES",NIH,,"$521,180"
Ovarian Cancer,2014,NCI,1ZIABC010830-08,,Mechanisms of non-classical multidrug resistance in cancer,"GOTTESMAN, MICHAEL",NIH,,"$1,433,179"
Ovarian Cancer,2014,NCI,1ZIABC010891-07,,Development of antibody-based cancer therapies,"HO, MITCHELL",NIH,,"$1,100,911"
Ovarian Cancer,2014,NCI,1ZIABC010973-07,,Analyses of human T regulatory cells,"TSANG, KWONG YOK",NIH,,"$680,834"
Ovarian Cancer,2014,NCI,1ZIABC011054-07,,Nuclear Factor-kappaB in Ovarian Cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$887,215"
Ovarian Cancer,2014,NCI,1ZIABC011055-07,,Serum Antibody Profiling with a Carbohydrate Microarray,"GILDERSLEEVE, JEFF",NIH,,"$614,793"
Ovarian Cancer,2014,NCI,1ZIABC011188-06,,Diazeniumdiolates as Broad-Spectrum Anticancer Agents,"KEEFER, LARRY",NIH,,"$757,433"
Ovarian Cancer,2014,NCI,1ZIABC011311-05,,Identification of genetic interactors of Brca2,"SHARAN, SHYAM",NIH,,"$369,367"
Ovarian Cancer,2014,NCI,1ZIABC011315-05,,Molecular characterization of endometrial cancer,"ANNUNZIATA, CHRISTINA",NIH,,"$59,148"
Ovarian Cancer,2014,NCI,1ZIABC011353-05,,Development and validation of preclinical mouse model for serous ovarian cancer,"VAN DYKE, TERRY",NIH,,"$1,012,184"
Ovarian Cancer,2014,NCI,1ZIABC011525-02,,Targeting DNA damage repair and related pathways in HRD-womens cancers,"LEE, JUNG-MIN",NIH,,"$773,642"
Ovarian Cancer,2014,NCI,1ZIABC011584-01,,Clinical trials in womens cancers,"ANNUNZIATA, CHRISTINA",NIH,,"$236,590"
Ovarian Cancer,2014,NCI,1ZIACP010126-19,,Hormone-Related Cancers,"BRINTON, LOUISE",NIH,,"$5,387,445"
Ovarian Cancer,2014,NCI,1ZIACP010128-19,,Therapeutic and Diagnostic Factors as Related to Cancer Risk,"BRINTON, LOUISE",NIH,,"$285,316"
Ovarian Cancer,2014,NCI,1ZIACP010142-16,,Genetic and Pharmacogenetic Modifiers of Cancer Risk and Intervention Outcomes,"GREENE, MARK",NIH,,"$452,492"
Ovarian Cancer,2014,NCI,1ZIACP010144-16,,Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes,"GREENE, MARK",NIH,,"$6,262,586"
Ovarian Cancer,2014,NCI,1ZIACP010145-15,,Intervention Trials in Persons at Increased Genetic Risk of Cancer,"GREENE, MARK",NIH,,"$534,681"
Ovarian Cancer,2014,NCI,1ZIACP010152-15,,PLCO Trial Etiologic and Early Marker Study,"HOOVER, ROBERT",NIH,,"$2,195,827"
Ovarian Cancer,2014,NCI,1ZIACP010182-12,,Epidemiologic Field Studies,"GAIL, MITCHELL",NIH,,"$200,971"
Ovarian Cancer,2014,NCI,1ZIACP010184-12,,Consultation and Collaboration,"GRAUBARD, BARRY",NIH,,"$1,977,655"
Ovarian Cancer,2014,NCI,1ZIACP010187-10,,Cancer Genetic Markers of Susceptibility,"HOOVER, ROBERT",NIH,,"$175,804"
Ovarian Cancer,2014,NCI,1ZIACP010188-10,,Risk prediction methods,"GAIL, MITCHELL",NIH,,"$782,343"
Ovarian Cancer,2014,NCI,1ZIACP010207-05,,PLCO EEMS and Extended Follow Up,"HOOVER, ROBERT",NIH,,"$979,773"
Ovarian Cancer,2014,NCI,1ZIASC006353-32,,Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy,"BRECHBIEL, MARTIN",NIH,,"$1,129,408"
Ovarian Cancer,2014,NCI,1ZICBC010930-07,,Molecular Cytogenetics Core,"ROSCHKE, ANNA",NIH,,"$326,193"
Ovarian Cancer,2014,NCI,N1CN25476A-92-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","O'BRIEN, BARBARA","WESTAT, INC.",,"$1,728,293"
Ovarian Cancer,2014,NCI,261200800001E-66-0-126,,DCP Center for Advanced Preclinical Research,"HEIMBROOK, DAVID","LEIDOS BIOMEDICAL RESEARCH, INC.",MD,"$170,900"
Ovarian Cancer,2014,NIAID,1ZIAAI001038-07,,Mechanisms of Antitumor Action of Human Interferon,"ZOON, KATHRYN",NIH,,"$200,282"
Ovarian Cancer,2014,NCI,261200900025I-0-26100027-1,,IGF::OT::IGF Conference support for GAME-ON Steering commitee meeting,"BURDETSKY, MATT",NIH,VA,"$50,052"
Ovarian Cancer,2014,NHGRI,1ZIAHG000120-18,,The role of the BRCA1 and BRCA2 gene in the pathogenesis of breast cancer,"BRODY, LAWRENCE",NIH,,"$121,079"
Ovarian Cancer,2014,NHGRI,1ZIAHG200323-10,,"Genomic, Epigenetic and Functional Analyses of Vertebrate Regulatory Regions","ELNITSKI, LAURA",NIH,,"$1,427,907"
